Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
暂无分享,去创建一个
G. Gibbons | A. Karchmer | G M Habershaw | M. Grayson | G. Habershaw | D. Freeman | F. Pomposelli | B. Rosenblum | E. Levin | G W Gibbons | B I Rosenblum | F B Pomposelli | D V Freeman | A W Karchmer | M L Grayson | E Levin | Habershaw Gm
[1] J. Fierer,et al. The fetid foot: lower-extremity infections in patients with diabetes mellitus. , 1979, Reviews of infectious diseases.
[2] D. Gerding,et al. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. , 1987, The American journal of medicine.
[3] J. Bartlett,et al. Aerobic and anaerobic bacteria in diabetic foot ulcers. , 1977, Annals of internal medicine.
[4] L. Peterson,et al. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. , 1987, Clinical therapeutics.
[5] Benjamin A Lipsky,et al. The diabetic foot. Soft tissue and bone infection. , 1990, Infectious disease clinics of North America.
[6] R. Kempczinski. Diabetic foot infections. Bacteriologic analysis , 1988 .
[7] L. Edler,et al. A sample size program for "proving the null hypothesis". , 1987, Controlled clinical trials.
[8] L. Peterson,et al. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. , 1989, The American journal of medicine.
[9] W. Joseph. Treatment of lower extremity infections in diabetics. , 1992, Drugs.
[10] G. Calandra,et al. Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics. , 1987, Scandinavian journal of infectious diseases. Supplementum.
[11] L. Gentry,et al. Imipenem/cilastatin in the treatment of osteomyelitis. , 1985, The American journal of medicine.
[12] L. Gerckens,et al. Antibacterial activity of imipenem: the first thienamycin antibiotic. , 1985, Reviews of infectious diseases.
[13] C. Sanders,et al. Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. , 1988, Reviews of infectious diseases.
[14] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[15] R. Sykes,et al. The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological Role , 1973 .
[16] Benjamin A Lipsky,et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. , 1990, Archives of internal medicine.
[17] L. Wheat,et al. Diabetic foot infections. Bacteriologic analysis. , 1986, Archives of internal medicine.
[18] J. Montgomerie,et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. , 1984, Reviews of infectious diseases.